MIMS news

New contraceptive shortages reported

New contraceptive shortages reported

Six contraceptive pills are currently unavailable to...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Antibiotic guidance issued for infected eczema

Antibiotic guidance issued for infected eczema

New guidance on antimicrobial prescribing for eczema...

MST Continus granules to be discontinued

MST Continus granules to be discontinued

All strengths of MST Continus (morphine) prolonged-release...

'Innovative' heart failure treatment recommended by NICE

'Innovative' heart failure treatment recommended by NICE

Dapagliflozin (Forxiga), the first SGLT2 inhibitor...

Pregabalin linked to severe respiratory depression in absence of opioids

Pregabalin linked to severe respiratory depression in absence of opioids

The MHRA advises prescribers to consider adjustment...

COVID-19 vaccines substantially reduce infection and hospitalisation risk, real-world data shows

COVID-19 vaccines substantially reduce infection and hospitalisation risk, real-world data shows

Preliminary data on the impact of COVID-19 vaccination...

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of short-acting bronchodilator inhalers in...

Phyllocontin to be discontinued

Phyllocontin to be discontinued

Phyllocontin Continus 225mg and Phyllocontin Forte...

Stay alert to postpartum bleeding risk with antidepressants, MHRA warns

Stay alert to postpartum bleeding risk with antidepressants, MHRA warns

Observational data suggest that the use of SSRIs and...

Join a MIMS Learning webinar on dermatology for skin of colour

Join a MIMS Learning webinar on dermatology for skin of colour

In this free live webinar for dermatologists, specialist...

Majority of COVID-19 vaccine side-effects 'mild and short lasting', MHRA analysis confirms

Majority of COVID-19 vaccine side-effects 'mild and short lasting', MHRA analysis confirms

Most adverse reactions reported for the Pfizer/BioNTech...

Oxford/AstraZeneca COVID-19 vaccine 'could substantially slow virus spread', study suggests

Oxford/AstraZeneca COVID-19 vaccine 'could substantially slow virus spread', study suggests

Researchers have reported the first evidence that a...

Third triple combination inhaler launched for COPD

Third triple combination inhaler launched for COPD

Trixeo Aerosphere is a new treatment for COPD patients,...

New LABA/LAMA combination inhaler increases choice for COPD patients

New LABA/LAMA combination inhaler increases choice for COPD patients

Bevespi Aerosphere (formoterol/glycopyrronium) is a...

Learn about neurological aspects of 'long COVID’ at a MIMS Learning webinar

Learn about neurological aspects of 'long COVID’ at a MIMS Learning webinar

Loss of taste and smell and neurological aspects of...

First triple combination MDI licensed for asthma

First triple combination MDI licensed for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) can...

Levosert IUS approved for extended contraceptive use

Levosert IUS approved for extended contraceptive use

Levosert (levonorgestrel) IUS can now be used to provide...

COVID-19 vaccination extended to over 70s and clinically vulnerable

COVID-19 vaccination extended to over 70s and clinically vulnerable

People aged over 70 and those who are clinically extremely...

FemSeven Conti back in stock

FemSeven Conti back in stock

FemSeven Conti (estradiol/levonorgestrel) HRT patches...